Annual accounts receivable:
$65.48M+$11.96M(+22.35%)Summary
- As of today (July 1, 2025), CPRX annual accounts receivable is $65.48 million, with the most recent change of +$11.96 million (+22.35%) on December 31, 2024.
- During the last 3 years, CPRX annual accounts receivable has risen by +$58.86 million (+889.21%).
- CPRX annual accounts receivable is now at all-time high.
Performance
CPRX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$71.27M+$5.79M(+8.84%)Summary
- As of today (July 1, 2025), CPRX quarterly accounts receivable is $71.27 million, with the most recent change of +$5.79 million (+8.84%) on March 31, 2025.
- Over the past year, CPRX quarterly accounts receivable has increased by +$10.77 million (+17.81%).
- CPRX quarterly accounts receivable is now at all-time high.
Performance
CPRX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CPRX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.4% | +17.8% |
| 3 y3 years | +889.2% | +575.4% |
| 5 y5 years | +521.4% | +930.0% |
CPRX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +889.2% | at high | +663.3% |
| 5 y | 5-year | at high | +993.6% | at high | +1172.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
CPRX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $71.27M(+8.8%) |
| Dec 2024 | $65.48M(+22.4%) | $65.48M(+12.4%) |
| Sep 2024 | - | $58.27M(+1.9%) |
| Jun 2024 | - | $57.17M(-5.5%) |
| Mar 2024 | - | $60.49M(+13.0%) |
| Dec 2023 | $53.51M(+412.6%) | $53.51M(+11.4%) |
| Sep 2023 | - | $48.05M(+12.3%) |
| Jun 2023 | - | $42.80M(+28.1%) |
| Mar 2023 | - | $33.40M(+220.0%) |
| Dec 2022 | $10.44M(+57.7%) | $10.44M(+11.8%) |
| Sep 2022 | - | $9.34M(-2.6%) |
| Jun 2022 | - | $9.59M(-9.1%) |
| Mar 2022 | - | $10.55M(+59.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $6.62M(+10.6%) | $6.62M(-0.1%) |
| Sep 2021 | - | $6.63M(+5.3%) |
| Jun 2021 | - | $6.29M(+12.3%) |
| Mar 2021 | - | $5.60M(-6.4%) |
| Dec 2020 | $5.99M(-43.2%) | $5.99M(+2.0%) |
| Sep 2020 | - | $5.87M(-13.2%) |
| Jun 2020 | - | $6.76M(-2.3%) |
| Mar 2020 | - | $6.92M(-34.3%) |
| Dec 2019 | $10.54M(>+9900.0%) | $10.54M(+4.4%) |
| Sep 2019 | - | $10.10M(-2.7%) |
| Jun 2019 | - | $10.38M(+43.1%) |
| Mar 2019 | - | $7.25M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Catalyst Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual accounts receivable year-on-year change?
- What is Catalyst Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Catalyst Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of CPRX is $65.48M
What is the all time high annual accounts receivable for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual accounts receivable is $65.48M
What is Catalyst Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, CPRX annual accounts receivable has changed by +$11.96M (+22.35%)
What is Catalyst Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of CPRX is $71.27M
What is the all time high quarterly accounts receivable for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly accounts receivable is $71.27M
What is Catalyst Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, CPRX quarterly accounts receivable has changed by +$10.77M (+17.81%)